Europe Tuberculosis Diagnostics Market Size & Outlook
Europe tuberculosis diagnostics market, 2018-2030 (US$M)
Related Markets
Europe tuberculosis diagnostics market highlights
- The Europe tuberculosis diagnostics market generated a revenue of USD 535.7 million in 2023.
- The market is expected to grow at a CAGR of 5.7% from 2024 to 2030.
- In terms of segment, detection of latent infection (skin test & igra) was the largest revenue generating test type in 2023.
- Detection of Drug Resistance (DST) is the most lucrative test type segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 535.7 million |
| Market revenue in 2030 | USD 789.3 million |
| Growth rate | 5.7% (CAGR from 2023 to 2030) |
| Largest segment | Detection of latent infection (skin test & igra) |
| Fastest growing segment | Detection of Drug Resistance (DST) |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Nucleic Acid Testing, Detection of Latent Infection (Skin Test & IGRA), Detection of Drug Resistance (DST), Other Methods, Phage Assay, Cytokine Detection Assay, Diagnostic Laboratory Methods, Radiographic Method |
| Key market players worldwide | Abbott Laboratories, Becton Dickinson & Co, Roche Holding AG ADR, Thermo Fisher Scientific Inc, BioMerieux SA, Qiagen NV, Hologic Inc, BD, Hain Lifescience, Cepheid |
Other key industry trends
- In terms of revenue, Europe region accounted for 24.6% of the global tuberculosis diagnostics market in 2023.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- MEA is the fastest growing regional market and is projected to reach USD 276.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Tuberculosis Diagnostics Market Scope
Tuberculosis Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe tuberculosis diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tuberculosis diagnostics market will help companies and investors design strategic landscapes.
Detection of latent infection (skin test & igra) was the largest segment with a revenue share of 41.27% in 2023. Horizon Databook has segmented the Europe tuberculosis diagnostics market based on nucleic acid testing, detection of latent infection (skin test & igra), detection of drug resistance (dst), other methods, phage assay, cytokine detection assay, diagnostic laboratory methods, radiographic method covering the revenue growth of each sub-segment from 2018 to 2030.
Europe accounted for around 18.0% in global TB diagnostics market. Projects such as European Tuberculosis Laboratory Initiative (ELI) 2012 are anticipated to govern growth of this region. The mission of ELI is to strengthen laboratory services in the European region with special focus on 18 high TB priority countries. This initiative is also focused on the control of drug-resistant TB.
Reasons to subscribe to Europe tuberculosis diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe tuberculosis diagnostics market databook
-
Our clientele includes a mix of tuberculosis diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe tuberculosis diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe tuberculosis diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe tuberculosis diagnostics market size, by country, 2018-2030 (US$M)
Europe Tuberculosis Diagnostics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
